Re: Important Issue for Immunity Credentials

HT to Juan C.
https://unherd.com/2020/04/how-far-away-are-immunity-passports/

I would ask: IWhat is the role of VC relative to local or decentralized
governance to solving this issue?

- Adrian


On Tue, Apr 7, 2020 at 3:10 PM D.W.Chadwick <info@verifiablecredentials.info>
wrote:

> Hi Moses
>
> over the last week or so we have developed a proof of concept COVID-19
> Immunity Certificate application demonstrator built on our application
> independent verifiable credential middleware. We would like to
> participate in challenge (1) headed by Victoriano. I am currently in the
> process of making a video of our demo
>
> Kind regards
>
> David
>
> On 08/04/2020 06:51, Moses Ma wrote:
> > Hi Christopher et al,
> >
> > You're absolutely right. This is why we have recruited: Dr. Ab
> > Osterhaus to join our team - he is one of the world's leading experts
> > in coronaviruses, and his team was first to sequence the SARS virus,
> > Dr. Tony Cox - a data scientist who specializes in epidemiology, and
> > Triall.io - a clinical research organization that has run over 30
> > Phase I-IV trials and is the developer of the first blockchain tool
> > for clinical trials. All of our proposed pilots will adhere to
> > clinical research methodologies that preserve patient privacy and
> > insure validated data production.
> >
> > However, what we could use more of are privacy experts who can quickly
> > produce innovative working solutions.
> >
> > Two challenges we've identified are: (1) the use of verifiable
> > credentials to serve as digital certificates of immunity, and (2) the
> > possibility of developing interoperable contact managers and globally
> > unique IDs to enable international travel. A big thanks to Victoriano
> > Giralt for stepping up to manage the first one, but I think we still
> > need to find a MacGyvered approach to solving the second... in a way
> > that has a low barrier to federation and adoption. To be brutally
> > honest, we are triaging a solution, and we need to see reality clearly
> > as to whether DIDs can add value short term.
> >
> > If you'd like to work on these sub-projects, please let me know.
> > Again, this is an action-primary team that will need to deliver
> > software on an super-agile basis.
> >
> > Anyway, I promised to share the recording of our first call so you
> > know what we're up to, and you can find it here:
> >
> https://www.dropbox.com/s/rqhpum88k28usti/Zoom-DefenderDIDcall-040620.mp4?dl=0
> >
> > Finally, I'll try to make time for CCG calls, but I'm getting
> > exponentially busier these days.
> >
> >
> > Stay healthy everyone!
> >
> > Moses
> >
> >
> > PS, thisis a very interesting article about user acceptance of contact
> > managers:https://045.medsci.ox.ac.uk/user-acceptance - respondents
> > were most concerned about “government using the app as an excuse to
> > increase surveillance after the epidemic”.
> >
> >
> > <https://045.medsci.ox.ac.uk/user-acceptance>
> >
> > On 4/7/20 10:19 AM, Christopher Allen wrote:
> >> As was discussed briefly in the call today, if we are going to talk
> >> about #Covid19 technology solutions, we must partner with health &
> >> epidemiological experts to do it right.
> >>
> >> For instance, it has been proposed that we support some kind of
> >> digital immunity certificate. Even if we ignore its possible
> >> human-rights & privacy risks, it can have still have risky public
> >> health care choices:
> >>
> >> https://unherd.com/2020/04/how-far-away-are-immunity-passports/
> >>
> >> “If you issue immunity passports on this basis, /barely a third /of
> >> the people you give them to will actually be immune. “There’s nothing
> >> peculiar about this statistically,” Kevin McConway, an emeritus
> >> professor of statistics at the Open University, told me. “It’s just
> >> Bayes’ theorem <https://en.wikipedia.org/wiki/Bayes%27_theorem>.” The
> >> likelihood of you having had Covid-19, if you’ve had a positive test,
> >> depends not just on the accuracy of the test but on the prevalence in
> >> the population you’re looking at.
> >> …
> >> In the end, that’s going to be a horribly cold-blooded calculation.
> >> If you let people out when they’re 90% likely to be immune, that
> >> means one person in 10 is going to be at risk of getting and
> >> spreading the disease. Is that risk a price worth paying for reducing
> >> the real costs (economic, social, physical, mental) of isolation? I
> >> don’t know and I’m glad I don’t have to work it out. But someone has
> >> to. And they’ll have to start by getting a reasonably effective test,
> >> and testing hundreds of thousands of people, to see how many of us
> >> have had it.”
> >>
> >> — Christopher Allen
> >
> >
> > --
> >
> > *Moses Ma | Managing Partner*
> >
> > moses.ma@futurelabconsulting.com | moses@ngenven.com
> >
> > v+1.415.568.1068 | skype mosesma | /linktr.ee/moses.tao/
> > <http://linktr.ee/moses.tao>
> >
> > FutureLab provides strategy, ideation and technology for breakthrough
> > innovation and third generation blockchains.
> >
> > Learn more at /www.futurelabconsulting.com/
> > <http://futurelabconsulting.com>. For calendar invites, please cc:
> > mosesma@gmail.com
> >
> >
> > Or whet your appetite by reading /Agile Innovation/
> > <
> http://www.amazon.com/Agile-Innovation-Revolutionary-Accelerate-Engagement/dp/B00SSRSZ9A>
>
> > | /Quantum Design Sprint/
> > <
> https://www.amazon.com/Quantum-Design-Sprint-Application-Disruptive/dp/1799143864>
>
> > | my blog at /psychologytoday.com/
> > <http://www.psychologytoday.com/blog/the-tao-innovation>.
> >
> > NOTICE TO RECIPIENT: THIS E-MAIL IS MEANT FOR ONLY THE INTENDED
> > RECIPIENT OF THE TRANSMISSION. IF YOU RECEIVED THIS E-MAIL IN ERROR,
> > ANY REVIEW, USE, DISSEMINATION, DISTRIBUTION, OR COPYING OF THIS
> > E-MAIL IS STRICTLY PROHIBITED. PLEASE NOTIFY THE SENDER IMMEDIATELY OF
> > THE ERROR BY RETURN E-MAIL AND PLEASE DELETE THIS MESSAGE FROM YOUR
> > SYSTEM. THIS EMAIL SHOULD NOT BE CONSIDERED BINDING; HARD COPY
> > DOCUMENTS ARE REQUIRED TO CREATE LEGALLY BINDING COMMITMENTS. FOR
> > CALENDAR INVITES, PLEASE CC: MOSESMA@GMAIL.COM
> >
>
>